Memphasys Limited

ASX (AUD): Memphasys Limited (MEM)

Last Price

0.01

Today's Change

+0.002 (25.00%)

Day's Change

0.008 - 0.01

Trading Volume

16,249,512

Overview

Market Cap

17 Million

Shares Outstanding

1 Billion

Avg Volume

2,148,745

Avg Price (50 Days)

0.01

Avg Price (200 Days)

0.01

PE Ratio

0.00

EPS

0.00

Earnings Announcement

24-Feb-2025

Previous Close

0.01

Open

0.01

Day's Range

0.008 - 0.01

Year Range

0.004 - 0.014

Trading Volume

16,249,512

Price Change Highlight

1 Day Change

25.00%

5 Day Change

66.67%

1 Month Change

100.00%

3 Month Change

25.00%

6 Month Change

25.00%

Ytd Change

25.00%

1 Year Change

-23.08%

3 Year Change

-89.30%

5 Year Change

-80.00%

10 Year Change

-98.52%

Max Change

-99.98%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix, a novel automated device for quickly and gently separating high quality sperm from a raw semen sample for use in human IVF procedures. In addition, the company's product pipeline include ROSA, a rapid oxidative stress assay; Samson Device, rapid equine pregnancy prediction assay; SemPort, a central lab human semen analysis from distantly located donors; and AI-Port. An ambient temperature semen transport device used for animal artificial insemination. Memphasys Limited was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. The company was incorporated in 2006 and is based in Homebush, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment